Plus: A 50-year timeline of UC San Diego’s School of Medicine, and the 2018 winners of the Greater San Diego Science and Engineering Fair
Plus: Are unicorns overrated, and what is the alternative?
Plus: Vividion Therapeutics and Celgene collaborate on intractable drug targets
Plus: TSRI scientists shed light on genome’s dark matter, and Fate Therapeutics wins CIRM grant
Plus: TSRI receives $10 million grant to find new therapies for alcohol abuse
Plus: TSRI receives donation for graduate program fellowships, and UC San Diego School of Medicine turns 50
Plus: Salk names interim president and Shanghai Pharmaceuticals plans to open research center in San Diego
Plus: TSRI scientists find therapeutic target for Marburg virus
Plus: Celgene buys Impact cancer drug, and Expansion Therapeutics plans to develop RNA-targeting drugs
Plus: San Diego EDC’s top 10 stories and what to do with a genetic testing kit
Plus: Fate Therapeutics makes five announcements and Michael Pellini joins Section 32 Venture Fund
Plus: Connect celebrates 30 years of Most Innovative New Product Awards and Synthorx had a big week
Plus: Salk Institute elects new chairman and Biolinq secures funding for wireless biosensor patch for diabetes
Plus: Tear Film completes $9 million Series A financing and Senomyx expands “Cool Program”
Plus: UCSD study gives clue to how one tumor suppressor fuels cancer
Plus: Two major bills affecting life sciences were signed into California law
Plus: Synthetic DNA developed for manomaterials in medicine, and clinical trail dashboard launched for stem cell-based treatments
Plus: TSRI’s HIV research center receives a $27 million grant, and California has a new stem cell law
Plus: Mapp Bio receives a $46 million federal contract, and this year’s Nobel Prizes have been announced
Plus: Biocom recognizes 15 leaders under 40, and a local startup gets funding to scale manufacturing of “miracle material”
